Osteonecrosis of the jaws (ONJ) represents a concern for patients taking antiresorptive drugs. The aim of this study was to test the hypothesis that preoperative individualized pharmacological control of the patient's osteometabolic profile could lead to predictable healing of the surgically treated region and minimize the incidence of complications.
from Imaging via alkiviadis.1961 on Inoreader http://ift.tt/2yCDO54
Τρίτη 14 Νοεμβρίου 2017
Patients' osteometabolic control improves the management of medication-related osteonecrosis of the jaw.
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
A study using a new computer-aided detection (CAD) algorithm found breast cancers... Read more on AuntMinnieEurope.com Related Reading: ...
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1TCfJ5D via IFTTT
-
The upper reaches of the Heihe River have been regarded as a hotspot for phytoecology, climate change, water resources and hydrology studies...
-
Objective: To describe the clinical workup and laparoscopic treatment of ovarian remnant syndrome in dogs and cats. Material and methods: Af...
-
Dicyclohexyl phthalate (DCHP) is one of the phthalate plasticizers. The objective of the present study was to investigate the effects of DCH...
-
Mystic men glimpse volcanoes and crystal valleys on gas giant. Plus: why brokers with slow cars are a safe bet, and the allergist whose name...
-
Antineutrophil cytoplasmic antibody- (ANCA-) associated vasculitis (AAV) is a multisystem autoimmune disease affecting mainly microscopic bl...
-
Cancers, Vol. 10, Pages 8: Modification of Epigenetic Histone Acetylation in Hepatocellular Carcinoma Cancers doi: 10.3390/cancers10010008 ...
-
Summary Many studies have shown that shorter sleep duration in childhood is associated with higher body mass index (BMI), and have propose...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου